DSpace at RU >

Browsing by Author Wittebol, S.

Full Text	Issue Date	Title	Author(s)
	2011	Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40	Rijneveld, A.W.; Holt, B. van der; Daenen, S.M.G.J.; Biemond, B.J.; Weerdt, O. de, et al
	2010	Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Janssen, J.J.M.; Holt, B. van der; Verhoef, G.E.; Smit, W.M., et al
	2010	A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.	Lokhorst, H.M.; Holt, B. van der; Zweegman, S.; Vellenga, E.; Croockewit, S., et al
	2008	Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.	Lokhorst, H.M.; Schmidt-Wolf, I.; Sonneveld, P.; Holt, B. van der; Martin, H., et al
	2008	Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J., et al
	2007	High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia : A prospective randomized phase III study	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Schattenberg, A.V.M.B.; Verdonck, L.F., et al
	1996	Prolonged enteroviral infection in a patient who developed pericarditis and heart failure after bone marrow transplantation	Galama, J.M.D.; Leeuw, N. de; Wittebol, S.; Peters, H.; Melchers, W.J.G.
	1995	Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+)	Raymakers, R.; Wittebol, S.; Pennings, A.; Linders, E.; Poddighe, P., et al
	1995	Residual normal, highly proliferative progenitors can be isolated from the CD34+/33-fraction of AML with a more differentiated phenotype (CD33+_.	Raymakers, R.A.P.; Wittebol, S.; Pennings, A.H.M.; Linders, E.H.P.; Poddighe, P.J., et al